Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
Lu, L., H. Zhang, M. Zhan, J. Jiang, H. Yin, D. J. Dauphars, S. Y. Li, Y. Li and Y. W. He (2020). "Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?" Front Cell Dev Biol 8: 677.
We suggested that the immunopathological pathway leading to COVID-19 mortality can be divided into three stages with distinct clinical features that can be used to guide therapeutic strategies. Choosing the correct target at the right time, combined with the right supplemental treatments is essential to preventing COVID-19 death.
分享